Skip to main content

Featured

Greek Tanker Struck by Missile in Black Sea, Crew Emerges Unharmed

  A Greek‑flagged tanker sailing near the Russian port of Novorossiysk was struck by a missile but remained operational, and all 24 crew members were confirmed safe.   A Greek‑owned and Greek‑flagged tanker sustained material damage after being hit by a missile while sailing approximately 14 nautical miles off the Russian port of Novorossiysk in the Black Sea. According to authorities, the vessel—operated by Maran Gas Maritime—was not carrying cargo at the time of the strike and continued to navigate safely following the incident.  All 24 crew members on board, including ten Greek nationals, thirteen Filipinos, and one Romanian, were reported to be in good health. The impact caused damage to the starboard side of the ship, but no assistance or towing was required. The tanker remained fully operational, and no environmental pollution was reported.  Greek officials have condemned the attack as dangerous and unacceptable, noting that the incident occurred amid height...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment